{"alanine aminotransferase increased": 5.58, "ascites": 23.7, "aspartate aminotransferase increased": 6.09, "blood bilirubin increased": 18.14, "cytopenia": 19.72, "death": 2.08, "febrile neutropenia": 10.56, "general physical health deterioration": 3.46, "graft versus host disease": 43.58, "hepatic function abnormal": 4.62, "liver disorder": 8.64, "multiple organ dysfunction syndrome": 9.9, "myelosuppression": 8.26, "neoplasm progression": 70.51, "neoplasm recurrence": 157.95, "neutropenia": 3.94, "neutrophil count decreased": 17.64, "off label use": 2.0, "pancytopenia": 6.81, "platelet count decreased": 16.56, "product use issue": 4.76, "sepsis": 3.88, "thrombocytopenia": 7.64, "tumour lysis syndrome": 30.91, "venoocclusive disease": 476.43, "venoocclusive liver disease": 1030.04, "weight increased": 2.43, "white blood cell count decreased": 10.72}